Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at June 30, 2014:
- 23,490 shares of Innate Pharma, and
- 312,376.44 euros in cash
As a reminder, at December 31, 2013, the following assets appeared on the liquidity account:
- 31,724 shares of Innate Pharma, and
- 301,816.06 euros in cash
| PR in English | 76.57 KB |
| CP en français | 28.58 KB |